{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T18:04:38Z","timestamp":1783533878070,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Shiga toxin (Stx)-induced hemolytic uremic syndrome (HUS) is a life-threatening complication associated with Stx-producing <jats:italic>Escherichia coli<\/jats:italic> infection. One critical barrier of understanding HUS is how Stx transports from infected intestine to kidney to cause HUS. Passive dissemination seems unlikely, while circulating blood cells have been debated to serve as the toxin carrier. Employing a murine model of Stx2-induced HUS with LPS priming (LPS-Stx2), we investigate how Stx causes HUS and identify possible toxin carrier. We show that peripheral white blood cells (WBC), but not other blood cells or cell-free plasma, carry Stx2 in LPS-Stx2-treated mice. The capability of WBC binding to Stx2 is confirmed in brief <jats:italic>ex vivo<\/jats:italic> Stx2 incubation, and adoptively transferring these Stx2-bound WBC into mice induces HUS. Cell separation further identifies a subpopulation in the CD11b<jats:sup>+<\/jats:sup> myeloid leukocytes not the CD11b<jats:sup>\u2212<\/jats:sup> lymphocytes group act as the toxin carrier, which captures Stx2 upon exposure and delivers the toxin <jats:italic>in vivo<\/jats:italic>. Interestingly, LPS-induced inflammation significantly augments these leukocytes for binding to Stx2 and enhances HUS toxicity. Our results demonstrate that a specific fraction of circulating leukocytes carry Stx2 and cause HUS <jats:italic>in vivo<\/jats:italic>, and that LPS priming enhances the carrier capacity and aggravates organ damage.<\/jats:p>","DOI":"10.1038\/s41598-018-22327-4","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T12:44:13Z","timestamp":1519735453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["LPS-primed CD11b+ leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice"],"prefix":"10.1038","volume":"8","author":[{"given":"Shuo","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Paluszynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koby","family":"Kidder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"22327_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/fpd.2013.1704","volume":"11","author":"SE Majowicz","year":"2014","unstructured":"Majowicz, S. E. et al. Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis. Foodborne Pathog Dis 11, 447\u2013455, https:\/\/doi.org\/10.1089\/fpd.2013.1704 (2014).","journal-title":"Foodborne Pathog Dis"},{"key":"22327_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s004670050018","volume":"14","author":"HM Verweyen","year":"2000","unstructured":"Verweyen, H. M., Karch, H., Brandis, M. & Zimmerhackl, L. B. Enterohemorrhagic Escherichia coli infections: following transmission routes. Pediatr Nephrol 14, 73\u201383 (2000).","journal-title":"Pediatr Nephrol"},{"key":"22327_CR3","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1007\/s00467-008-0935-6","volume":"23","author":"J Scheiring","year":"2008","unstructured":"Scheiring, J., Andreoli, S. P. & Zimmerhackl, L. B. Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS). Pediatr Nephrol 23, 1749\u20131760, https:\/\/doi.org\/10.1007\/s00467-008-0935-6 (2008).","journal-title":"Pediatr Nephrol"},{"key":"22327_CR4","doi-asserted-by":"publisher","unstructured":"Karpman, D. & Stahl, A. L. Enterohemorrhagic Escherichia coli Pathogenesis and the Host Response. Microbiol Spectr 2, https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0009-2013 (2014).","DOI":"10.1128\/microbiolspec.EHEC-0009-2013"},{"key":"22327_CR5","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1203\/00006450-200212000-00019","volume":"52","author":"F Proulx","year":"2002","unstructured":"Proulx, F. et al. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome. Pediatr Res 52, 928\u2013934, https:\/\/doi.org\/10.1203\/00006450-200212000-00019 (2002).","journal-title":"Pediatr Res"},{"key":"22327_CR6","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.3390\/toxins2061515","volume":"2","author":"MS Lee","year":"2010","unstructured":"Lee, M. S., Cherla, R. P. & Tesh, V. L. Shiga toxins: intracellular trafficking to the ER leading to activation of host cell stress responses. Toxins (Basel) 2, 1515\u20131535, https:\/\/doi.org\/10.3390\/toxins2061515 (2010).","journal-title":"Toxins (Basel)"},{"key":"22327_CR7","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ki.1995.261","volume":"48","author":"G Remuzzi","year":"1995","unstructured":"Remuzzi, G. & Ruggenenti, P. The hemolytic uremic syndrome. Kidney Int 48, 2\u201319 (1995).","journal-title":"Kidney Int"},{"key":"22327_CR8","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/joim.12546","volume":"281","author":"D Karpman","year":"2017","unstructured":"Karpman, D., Loos, S., Tati, R. & Arvidsson, I. Haemolytic uraemic syndrome. J Intern Med 281, 123\u2013148, https:\/\/doi.org\/10.1111\/joim.12546 (2017).","journal-title":"J Intern Med"},{"key":"22327_CR9","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1128\/CMR.11.3.450","volume":"11","author":"JC Paton","year":"1998","unstructured":"Paton, J. C. & Paton, A. W. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin Microbiol Rev 11, 450\u2013479 (1998).","journal-title":"Clin Microbiol Rev"},{"key":"22327_CR10","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1172\/JCI118168","volume":"96","author":"MS Jacewicz","year":"1995","unstructured":"Jacewicz, M. S. et al. Maturational regulation of globotriaosylceramide, the Shiga-like toxin 1 receptor, in cultured human gut epithelial cells. J Clin Invest 96, 1328\u20131335, https:\/\/doi.org\/10.1172\/JCI118168 (1995).","journal-title":"J Clin Invest"},{"key":"22327_CR11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1128\/iai.63.3.1138-1141.1995","volume":"63","author":"GT Keusch","year":"1995","unstructured":"Keusch, G. T. et al. Globotriaosylceramide, Gb3, is an alternative functional receptor for Shiga-like toxin 2e. Infect Immun 63, 1138\u20131141 (1995).","journal-title":"Infect Immun"},{"key":"22327_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00418-008-0417-8","volume":"130","author":"GL Kolling","year":"2008","unstructured":"Kolling, G. L., Obata, F., Gross, L. K. & Obrig, T. G. Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system. Histochem Cell Biol 130, 157\u2013164, https:\/\/doi.org\/10.1007\/s00418-008-0417-8 (2008).","journal-title":"Histochem Cell Biol"},{"key":"22327_CR13","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1046\/j.1365-2958.1998.00890.x","volume":"28","author":"MN Neely","year":"1998","unstructured":"Neely, M. N. & Friedman, D. I. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 28, 1255\u20131267 (1998).","journal-title":"Mol Microbiol"},{"key":"22327_CR14","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/MNH.0b013e328354a62e","volume":"21","author":"TN Petruzziello-Pellegrini","year":"2012","unstructured":"Petruzziello-Pellegrini, T. N. & Marsden, P. A. Shiga toxin-associated hemolytic uremic syndrome: advances in pathogenesis and therapeutics. Curr Opin Nephrol Hypertens 21, 433\u2013440, https:\/\/doi.org\/10.1097\/MNH.0b013e328354a62e (2012).","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"22327_CR15","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/INF.0b013e3182074d22","volume":"30","author":"M Brigotti","year":"2011","unstructured":"Brigotti, M. et al. Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome. Pediatr Infect Dis J 30, 486\u2013490, https:\/\/doi.org\/10.1097\/INF.0b013e3182074d22 (2011).","journal-title":"Pediatr Infect Dis J"},{"key":"22327_CR16","doi-asserted-by":"publisher","first-page":"e564","DOI":"10.1111\/apa.13211","volume":"104","author":"X He","year":"2015","unstructured":"He, X. et al. Serum Shiga toxin 2 values in patients during acute phase of diarrhoea-associated haemolytic uraemic syndrome. Acta Paediatr 104, e564\u2013568, https:\/\/doi.org\/10.1111\/apa.13211 (2015).","journal-title":"Acta Paediatr"},{"key":"22327_CR17","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1007\/s00467-007-0512-4","volume":"22","author":"JM Geelen","year":"2007","unstructured":"Geelen, J. M., van der Velden, T. J., van den Heuvel, L. P. & Monnens, L. A. Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr Nephrol 22, 1181\u20131187, https:\/\/doi.org\/10.1007\/s00467-007-0512-4 (2007).","journal-title":"Pediatr Nephrol"},{"key":"22327_CR18","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1182\/blood.V95.11.3396","volume":"95","author":"DM te Loo","year":"2000","unstructured":"te Loo, D. M. et al. Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome. Blood 95, 3396\u20133402 (2000).","journal-title":"Blood"},{"key":"22327_CR19","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1189\/jlb.0308157","volume":"84","author":"M Brigotti","year":"2008","unstructured":"Brigotti, M. et al. Interactions between Shiga toxins and human polymorphonuclear leukocytes. J Leukoc Biol 84, 1019\u20131027, https:\/\/doi.org\/10.1189\/jlb.0308157 (2008).","journal-title":"J Leukoc Biol"},{"key":"22327_CR20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.V124800","volume":"12","author":"DM Te Loo","year":"2001","unstructured":"Te Loo, D. M., van Hinsbergh, V. W., van den Heuvel, L. P. & Monnens, L. A. Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome. J Am Soc Nephrol 12, 800\u2013806 (2001).","journal-title":"J Am Soc Nephrol"},{"key":"22327_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/cyto.b.20022","volume":"61","author":"PL Tazzari","year":"2004","unstructured":"Tazzari, P. L. et al. Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome. Cytometry B Clin Cytom 61, 40\u201344, https:\/\/doi.org\/10.1002\/cyto.b.20022 (2004).","journal-title":"Cytometry B Clin Cytom"},{"key":"22327_CR22","doi-asserted-by":"publisher","first-page":"4748","DOI":"10.4049\/jimmunol.1300122","volume":"191","author":"M Brigotti","year":"2013","unstructured":"Brigotti, M. et al. Identification of TLR4 as the receptor that recognizes Shiga toxins in human neutrophils. J Immunol 191, 4748\u20134758, https:\/\/doi.org\/10.4049\/jimmunol.1300122 (2013).","journal-title":"J Immunol"},{"key":"22327_CR23","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1128\/IAI.01594-06","volume":"75","author":"MJ Flagler","year":"2007","unstructured":"Flagler, M. J., Strasser, J. E., Chalk, C. L. & Weiss, A. A. Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis. Infect Immun 75, 760\u2013765, https:\/\/doi.org\/10.1128\/IAI.01594-06 (2007).","journal-title":"Infect Immun"},{"key":"22327_CR24","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/ndt\/gfl688","volume":"22","author":"JM Geelen","year":"2007","unstructured":"Geelen, J. M. et al. Lack of specific binding of Shiga-like toxin (verocytotoxin) and non-specific interaction of Shiga-like toxin 2 antibody with human polymorphonuclear leucocytes. Nephrol Dial Transplant 22, 749\u2013755, https:\/\/doi.org\/10.1093\/ndt\/gfl688 (2007).","journal-title":"Nephrol Dial Transplant"},{"key":"22327_CR25","doi-asserted-by":"publisher","first-page":"6680","DOI":"10.1128\/IAI.72.11.6680-6684.2004","volume":"72","author":"KR Winter","year":"2004","unstructured":"Winter, K. R., Stoffregen, W. C. & Dean-Nystrom, E. A. Shiga toxin binding to isolated porcine tissues and peripheral blood leukocytes. Infect Immun 72, 6680\u20136684, https:\/\/doi.org\/10.1128\/IAI.72.11.6680-6684.2004 (2004).","journal-title":"Infect Immun"},{"key":"22327_CR26","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1099\/jmm.0.47282-0","volume":"56","author":"TP Griener","year":"2007","unstructured":"Griener, T. P., Mulvey, G. L., Marcato, P. & Armstrong, G. D. Differential binding of Shiga toxin 2 to human and murine neutrophils. J Med Microbiol 56, 1423\u20131430, https:\/\/doi.org\/10.1099\/jmm.0.47282-0 (2007).","journal-title":"J Med Microbiol"},{"key":"22327_CR27","doi-asserted-by":"publisher","first-page":"e1004619","DOI":"10.1371\/journal.ppat.1004619","volume":"11","author":"AL Stahl","year":"2015","unstructured":"Stahl, A. L. et al. A novel mechanism of bacterial toxin transfer within host blood cell-derived microvesicles. PLoS Pathog 11, e1004619, https:\/\/doi.org\/10.1371\/journal.ppat.1004619 (2015).","journal-title":"PLoS Pathog"},{"key":"22327_CR28","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1681\/ASN.2006050419","volume":"17","author":"TR Keepers","year":"2006","unstructured":"Keepers, T. R., Psotka, M. A., Gross, L. K. & Obrig, T. G. A murine model of HUS: Shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease. J Am Soc Nephrol 17, 3404\u20133414, https:\/\/doi.org\/10.1681\/ASN.2006050419 (2006).","journal-title":"J Am Soc Nephrol"},{"key":"22327_CR29","doi-asserted-by":"publisher","first-page":"258185","DOI":"10.1155\/2011\/258185","volume":"2011","author":"KL Mohawk","year":"2011","unstructured":"Mohawk, K. L. & O\u2019Brien, A. D. Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol 2011, 258185, https:\/\/doi.org\/10.1155\/2011\/258185 (2011).","journal-title":"J Biomed Biotechnol"},{"key":"22327_CR30","doi-asserted-by":"publisher","first-page":"e6990","DOI":"10.1371\/journal.pone.0006990","volume":"4","author":"AL Stahl","year":"2009","unstructured":"Stahl, A. L., Sartz, L., Nelsson, A., Bekassy, Z. D. & Karpman, D. Shiga toxin and lipopolysaccharide induce platelet-leukocyte aggregates and tissue factor release, a thrombotic mechanism in hemolytic uremic syndrome. PLoS One 4, e6990, https:\/\/doi.org\/10.1371\/journal.pone.0006990 (2009).","journal-title":"PLoS One"},{"key":"22327_CR31","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00467-003-1395-7","volume":"19","author":"M Ikeda","year":"2004","unstructured":"Ikeda, M., Ito, S. & Honda, M. Hemolytic uremic syndrome induced by lipopolysaccharide and Shiga-like toxin. Pediatr Nephrol 19, 485\u2013489, https:\/\/doi.org\/10.1007\/s00467-003-1395-7 (2004).","journal-title":"Pediatr Nephrol"},{"key":"22327_CR32","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1128\/iai.62.11.5085-5094.1994","volume":"62","author":"VL Tesh","year":"1994","unstructured":"Tesh, V. L., Ramegowda, B. & Samuel, J. E. Purified Shiga-like toxins induce expression of proinflammatory cytokines from murine peritoneal macrophages. Infect Immun 62, 5085\u20135094 (1994).","journal-title":"Infect Immun"},{"key":"22327_CR33","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1086\/314982","volume":"180","author":"B Ramegowda","year":"1999","unstructured":"Ramegowda, B., Samuel, J. E. & Tesh, V. L. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis 180, 1205\u20131213, https:\/\/doi.org\/10.1086\/314982 (1999).","journal-title":"J Infect Dis"},{"key":"22327_CR34","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan, M. A. Determination of 50% endpoint titer using a simple formula. World J Virol 5, 85\u201386, https:\/\/doi.org\/10.5501\/wjv.v5.i2.85 (2016).","journal-title":"World J Virol"},{"key":"22327_CR35","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1084\/jem.160.6.1767","volume":"160","author":"A Donohue-Rolfe","year":"1984","unstructured":"Donohue-Rolfe, A., Keusch, G. T., Edson, C., Thorley-Lawson, D. & Jacewicz, M. Pathogenesis of Shigella diarrhea. IX. Simplified high yield purification of Shigella toxin and characterization of subunit composition and function by the use of subunit-specific monoclonal and polyclonal antibodies. J Exp Med 160, 1767\u20131781 (1984).","journal-title":"J Exp Med"},{"key":"22327_CR36","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0041-0101(00)00135-5","volume":"39","author":"M Brigotti","year":"2001","unstructured":"Brigotti, M. et al. Shiga toxin 1: damage to DNA in vitro. Toxicon 39, 341\u2013348 (2001).","journal-title":"Toxicon"},{"key":"22327_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1432-1033.1988.tb13756.x","volume":"171","author":"Y Endo","year":"1988","unstructured":"Endo, Y. et al. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 171, 45\u201350 (1988).","journal-title":"Eur J Biochem"},{"key":"22327_CR38","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1203\/00006450-199901000-00022","volume":"45","author":"H Uchida","year":"1999","unstructured":"Uchida, H., Kiyokawa, N., Horie, H., Fujimoto, J. & Takeda, T. The detection of Shiga toxins in the kidney of a patient with hemolytic uremic syndrome. Pediatr Res 45, 133\u2013137, https:\/\/doi.org\/10.1203\/00006450-199901000-00022 (1999).","journal-title":"Pediatr Res"},{"key":"22327_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1189\/jlb.0709475","volume":"88","author":"M Brigotti","year":"2010","unstructured":"Brigotti, M. et al. Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration. J Leukoc Biol 88, 201\u2013210, https:\/\/doi.org\/10.1189\/jlb.0709475 (2010).","journal-title":"J Leukoc Biol"},{"key":"22327_CR40","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1128\/iai.60.4.1536-1543.1992","volume":"60","author":"CB Louise","year":"1992","unstructured":"Louise, C. B. & Obrig, T. G. Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro. Infect Immun 60, 1536\u20131543 (1992).","journal-title":"Infect Immun"},{"key":"22327_CR41","doi-asserted-by":"publisher","unstructured":"Obata, F. & Obrig, T. Role of Shiga\/Vero toxins in pathogenesis. Microbiol Spectr 2, https:\/\/doi.org\/10.1128\/microbiolspec.EHEC-0005-2013 (2014).","DOI":"10.1128\/microbiolspec.EHEC-0005-2013"},{"key":"22327_CR42","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1159\/000088523","volume":"25","author":"F Clayton","year":"2005","unstructured":"Clayton, F. et al. Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome. Am J Nephrol 25, 536\u2013540, https:\/\/doi.org\/10.1159\/000088523 (2005).","journal-title":"Am J Nephrol"},{"key":"22327_CR43","doi-asserted-by":"publisher","first-page":"844","DOI":"10.4049\/jimmunol.1101736","volume":"188","author":"Z Bian","year":"2012","unstructured":"Bian, Z., Guo, Y., Ha, B., Zen, K. & Liu, Y. Regulation of the inflammatory response: enhancing neutrophil infiltration under chronic inflammatory conditions. J Immunol 188, 844\u2013853, https:\/\/doi.org\/10.4049\/jimmunol.1101736 (2012).","journal-title":"J Immunol"},{"key":"22327_CR44","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11894-016-0487-z","volume":"18","author":"EM DeFilippis","year":"2016","unstructured":"DeFilippis, E. M., Longman, R., Harbus, M., Dannenberg, K. & Scherl, E. J. Crohn\u2019s Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies. Curr Gastroenterol Rep 18, 13, https:\/\/doi.org\/10.1007\/s11894-016-0487-z (2016).","journal-title":"Curr Gastroenterol Rep"},{"key":"22327_CR45","doi-asserted-by":"publisher","first-page":"3689","DOI":"10.1128\/IAI.00616-10","volume":"78","author":"EK Lentz","year":"2010","unstructured":"Lentz, E. K., Cherla, R. P., Jaspers, V., Weeks, B. R. & Tesh, V. L. Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage. Infect Immun 78, 3689\u20133699, https:\/\/doi.org\/10.1128\/IAI.00616-10 (2010).","journal-title":"Infect Immun"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22327-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22327-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T03:10:35Z","timestamp":1671592235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-22327-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["22327"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-22327-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"3994"}}